Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12978498 | 0.82 | LMNA (0.45) | TSHRKDM4EHIF1AMAPTLMNA | |
| SCHEMBL27250603 | 0.76 | PLA2G4B (0.42) | TSHRLMNAPPARG | |
| SCHEMBL12222347 | 0.75 | LMNA (0.43) | TSHRMAPK1KDM4EHIF1AMAPT | |
| SCHEMBL12222349 | 0.74 | ADRB2 (0.46) | KDM4EMAPTLMNAALDH1A1CYP3A4 | |
| SCHEMBL12222360 | 0.74 | LMNA (0.53) | TSHRMAPK1KDM4EHIF1AMAPT | |
| SCHEMBL12172005 | 0.73 | LMNA (0.43) | LMNA | |
| SCHEMBL14904490 | 0.72 | LMNA (0.50) | TSHRKDM4EHIF1AMAPTLMNA | |
| SCHEMBL27250609 | 0.71 | MAPK1 (0.43) | TSHRMAPK1MAPTLMNASMN1; SMN2 | |
| SCHEMBL14904491 | 0.71 | PLA2G4B (0.53) | TSHRMAPK1KDM4EHIF1A | |
| SCHEMBL2720404 | 0.70 | MAPK1 (0.50) | TSHRMAPK1KDM4EHIF1AHSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209160-A1 | POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER | STEPAN COMPANY | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209160-A1 | POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER | TYR, PAOX, NAPEPLD | TSHR 2537/4885MAPK1 3009/4885KDM4E 3812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.